[Inclusion body myositis after interferon-alpha treatment in a patient with HCV and HTLV-1 infection].


We report the first case of inclusion body myositis (IBM) which occurred after interferon-alpha treatment for chronic hepatitis C. A 63-year-old man contracted hepatitis C virus (HCV) and human T cell leukemia virus type 1 (HTLV-1) from a blood transfusion at age of 18. At age 57, he was treated with interferon-alpha (IFN alpha) for chronic hepatitis C. A… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.